ClinVar Miner

Submissions for variant NM_001110792.2(MECP2):c.553C>G (p.Pro185Ala)

gnomAD frequency: 0.00002  dbSNP: rs61748427
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel RCV000133148 SCV002769699 likely benign Rett syndrome 2022-10-11 reviewed by expert panel curation The p.Pro173Ala variant in MECP2 (NM_004992.3) has been reported in an individual with a clinical phenotype suggestive of Rett syndrome; this individual was reported to have a second variant in MECP2 that was classified as Pathogenic (PMID 11241840). The p.Pro173Ala variant in MECP2 (NM_004992.3) is observed in at least 2 unaffected individuals (internal database - GeneDx; internal database - Invitae) (BS2). The p.Pro173Ala variant is found in at least 2 patients with an alternate molecular basis of disease (internal database - GeneDx; internal database - Invitae) (BP5). The p.Pro173Ala variant in MECP2 is present in 3 female and 2 male individual(s) in gnomAD (0.0024%) (not sufficient to meet BS1 criteria). In summary, the p.Pro173Ala variant in MECP2 is classified as Likely Benign based on the ACMG/AMP criteria (BS2, BP5).
CeGaT Center for Human Genetics Tuebingen RCV000513430 SCV000609421 uncertain significance not provided 2017-02-01 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000766084 SCV000897559 uncertain significance Severe neonatal-onset encephalopathy with microcephaly; Syndromic X-linked intellectual disability Lubs type; X-linked intellectual disability-psychosis-macroorchidism syndrome; Rett syndrome; Autism, susceptibility to, X-linked 3 2018-10-31 criteria provided, single submitter clinical testing
GeneDx RCV000513430 SCV001764578 likely benign not provided 2019-05-08 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 11241840)
Labcorp Genetics (formerly Invitae), Labcorp RCV002055855 SCV002322795 likely benign Severe neonatal-onset encephalopathy with microcephaly 2023-12-25 criteria provided, single submitter clinical testing
Centre for Population Genomics, CPG RCV000133148 SCV004808751 likely benign Rett syndrome 2024-03-14 criteria provided, single submitter curation This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely benign. At least the following criteria are met: The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2). Variant is found in an individual with an alternate molecular basis of disease (BP5).
RettBASE RCV000133148 SCV000188140 uncertain significance Rett syndrome 2002-09-05 no assertion criteria provided curation
PreventionGenetics, part of Exact Sciences RCV004532604 SCV004712468 likely benign MECP2-related disorder 2022-02-23 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.